198
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Increasing the efficiency of the retinoblastoma brachytherapy protocol with ultrasonic hyperthermia and gold nanoparticles: a rabbit model

, , , &
Pages 1614-1627 | Received 31 Mar 2020, Accepted 04 Oct 2020, Published online: 09 Nov 2020

References

  • Acar H. 2010. Verification of plaque simulator dose distributions using Gafchromic® EBT film. Turk Onkoloji Dergisi. 25(4):150–156.
  • Alamolhoda M, Mokhtari-Dizaji M, Barati AH, Hasanzadeh H. 2012. Comparing the in vivo sonodynamic effects of dual- and single-frequency ultrasound in breast adenocarcinoma. J Med Ultrasonics. 39(3):115–125.
  • Alberti WE, Sagerman RH. 2003. Radiotherapy of intraocular and orbital tumors. Diagnosis and management of retinoblastoma. Berlin, Heidelberg (Germany): Springer-Verlag; p. 95–118.
  • Arslan SA, Ozdemir N, Sendur MA, Eren T, Ozturk HF, Aral IP, Soykut ED, Inan GA. 2017. Hyperthermia and radiotherapy combination for locoregional recurrences of breast cancer: a review. Breast Cancer Manag. 6(4):117–126.
  • Blanco PL, Marshall JCA, Antecka E, Callejo SA, Souza Filho JP, Saraiva V, Burnier MN. 2005. Characterization of ocular and metastatic uveal melanoma in an animal model. Invest Ophthalmol Vis Sci. 46(12):4376–4382.
  • Chatterjee DK, Diagaradjane P, Krishnan S. 2011. Nanoparticle-mediated hyperthermia in cancer therapy. Ther Deliv. 2(8):1001–1014.
  • Chawla B, Jain A, Azad R. 2013. Conservative treatment modalities in retinoblastoma. Indian J Ophthalmol. 61(9):479–485.
  • Chen AL, Jackson MA, Lin AY, Figueroa ER, Hu YS, Evans ER, Asthana V, Young JK, Drezek RA. 2016. Changes in optical properties of plasmonic nanoparticles in cellular environments are modulated by nanoparticle pegylation and serum conditions. Nanoscale Res Lett. 11(1):303–312.
  • Crezee H, van Leeuwen CM, Oei AL, Stalpers LJA, Bel A, Franken NA, Kok HP. 2016. Thermoradiotherapy planning: integration in routine clinical practice. Int J Hyperthermia. 32(1):41–49.
  • Datta NR, Ordonez SG, Gaipl US, Paulides MM, Crezee H, Gellermann J, Marder D, Puric E, Bodis S. 2015. Local hyperthermia combined with radiotherapy and-/or chemotherapy: recent advances and promises for the future. Cancer Treat Rev. 41(9):742–753.
  • Dimitriou NM, Pavlopoulo A, Tremi I, Kouloulias V, Tsigaridas G, Georgakilas AG. 2019. Prediction of gold nanoparticle and microwave-induced hyperthermia effects on tumor control via a simulation approach. Nanomaterials. 9(2):167–119.
  • Elming PB, Sørensen BS, Oei AL, Franken NAP, Crezee J, Overgaard J, Horsman MR. 2019. Hyperthermia: the optimal treatment to overcome radiation resistant hypoxia. Cancers. 11(1):60.
  • Federico S, Brennan R, Dyer MA. 2011. Childhood cancer and developmental biology a crucial partnership. Curr Top Dev Biol. 94:1–13.
  • Francis JH, Barker CA, Wolden SL, McCormick B, Segal K, Cohen G, Gobin YP, Marr BP, Brodie SE, Dunkel IJ, et al. 2013. Salvage/adjuvant brachytherapy after ophthalmic artery chemosurgery for intraocular retinoblastoma. Int J Radiat Oncol Biol Phys. 87(3):517–523.
  • Gao F, Al-Azayzih A, Somanath PR. 2015. Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis. Oncotarget. 6(8):5947–5962.
  • Habash RW, Bansal R, Krewski D, Alhafid HT. 2006. Thermal therapy, part 2: hyperthermia techniques. Crit Rev Biomed Eng. 34(6):491–542.
  • Hainfeld JF, Lin L, Slatkin DN, Avraham Dilmanian F, Vadas TM, Smilowitz HM. 2014. Gold nanoparticle hyperthermia reduces radiotherapy dose. Nanomedicine. 10(8):1609–1617.
  • Hand JW. 1998. Ultrasound therapy and surgery. Ultrasound hyperthermia and the prediction of heating. In: Duck FA, Baker AC, Starritt HC, editors. Ultrasound in medicine. Bristol (UK); Philadelphia (PA): Institute of Physics Publishing; chapter 8.
  • Kang SJ, Grossniklaus HE. 2011. Rabbit model of retinoblastoma. J Biomed Biotechnol. 2011:394730.
  • Kim H, Nguyen VP, Manivasagan P, Jung MJ, Kim SW, Oh J, Kang HW. 2017. Doxorubicin-fucoidan-gold nanoparticles composite for dual-chemo-photothermal treatment on eye tumors. Oncotarget. 8(69):113719–113733.
  • Kim JW, Jacobsen B, Zolfaghari E, Ferrario A, Chevez-Barrios P, Berry JL, Lee DK, Rico G, Kumar N, Nayak S, et al. 2012. Role of dilute alcohol in the removal of fine wrinkles from paraffin sections: a histo-technical Study. Int J Morphol. 30(1):45–48.
  • Kim JW, Jacobsen B, Zolfaghari E, Ferrario A, Chevez-Barrios P, Berry JL, Lee DK, Rico G, Madi I, Rao N, et al. 2017. Rabbit model of ocular indirect photodynamic therapy using a retinoblastoma xenograft. Graefes Arch Clin Exp Ophthalmol. 255(12):2363–2373.
  • Krasovitski B, Frenkel V, Shoham S, Kimmel E. 2011. Intramembrane cavitation as a unifying mechanism for ultrasound-induced bioeffects. PNAS. 108(8):3258–3263.
  • Krintz A, Hanson WF, Ibbott GS, Followill DS. 2002. Verification of plaque simulator dose distribution using radiochromic film. Med Phys. 29(6):1220–1221.
  • Lohrabian V, Sheibani S, Aghamiri MR, Ghozati B, Pourbeigi H, Baghani HR. 2013. Determination of dosimetric characteristics of IrSeed 125I brachytherapy source. Iran J Med Phys. 10(3):109–117.
  • Martínez-Torres AC, Zarate-Triviño DG, Lorenzo-Anota HY, Ávila-Ávila A, Rodríguez-Abrego C, Rodríguez-Padilla C. 2018. Chitosan gold nanoparticles induce cell death in HeLa and MCF-7 cells through reactive oxygen species production. Int J Nanomedicine. 13:3235–3250.
  • Mieler WF. 1997. Concurrent versus sequential application of ferromagnetic hyperthermia and 125 I brachytherapy of melanoma in an animal model. Trans Am Ophthalmol Soc. 95:611–628.
  • Moradi S, Mokhtari-Dizaji M, Ghassemi F, Sheibani S, Asadi Amoli F. 2020. The effect of ultrasound hyperthermia with gold nanoparticles on retinoblastoma Y79 cells. Gold Bull. 53(2):111–120.
  • Oei AL, Vriend LEM, Crezee J, Franken NAP, Krawczyk PM. 2015. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol. 10(1):13.
  • Peddada KV, Sangani R, Menon H, Verma V. 2019. Complications and adverse events of plaque brachytherapy for ocular melanoma. J Contemp Brachytherapy. 11(4):392–397.
  • Peeken JC, Vaupel P, Combs SE. 2017. Integrating hyperthermia into modern radiation oncology: what evidence is necessary? Front. Front Oncol. 7:132.
  • Pekacka A. 2020. The role of intraarterial chemotherapy in the management of retinoblastoma. J Ophthalmol. 2020:3638410.
  • Phung DC, Nguyen HT, Tran TTP, Jin SG, Yong CS, Truong DH, Tran TH, Kim JO. 2019. Combined hyperthermia and chemotherapy as a synergistic anticancer treatment. J Pharm Investig. 49(5):519–526.
  • Poder J, Corde S. 2013. I-125 ROPES eye plaque dosimetry: validation of a commercial 3D ophthalmic brachytherapy treatment planning system and independent dose calculation software with GafChromic® EBT3 films. Med Phys. 40(12):121709.
  • Proia DA, Kaufmann GF. 2015. Targeting heat-shock protein 90 (HSP90) as a complementary strategy to immune checkpoint blockade for cancer therapy. Cancer Immunol Res. 3(6):583–589.
  • Qi LF, Xu ZR, Li Y, Jiang X, Han XY. 2005. In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J Gastroenterol. 11(33):5136–5141.
  • Seifert G, Budach V, Keilholz U, Wust P, Eggert A, Ghadjar P. 2016. Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives. Radiat Oncol. 11(65):1–7.
  • Shah NV, Houston SK, Murray TG. 2013. Retinoblastoma and treatment: a current evaluation of advanced therapy. World J Phamacol. 2(3):65–72.
  • Shields CL, Mashayekhi A, Sun H, Uysal Y, Friere J, Komarnicky L, Shields JA. 2006. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors. Ophthalmology. 113(11):2087–2092.
  • Singh U, Katoch D, Kaur S, Dogra MR, Bansal D, Kapoor R. 2018. Retinoblastoma: a sixteen-year review of the presentation, treatment, and outcome from a tertiary care institute in northern India. Ocul Oncol Pathol. 4(1):23–32.
  • Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC. 2019. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 69(3):184–210.
  • Wang Y, Hong W, Sh C, Zhang Y, Meng D, Shi F, Su J, Yang Y, Ma H, Liu R, et al. 2020. Outcomes for hyperthermia combined with concurrent radiochemotherapy for patients with cervical cancer. Int J Radiat Oncol Biol Phys. 107(3):499–511.
  • Wei D, Qian W. 2008. Facile synthesis of Ag and Au nanoparticles utilizing chitosan as a mediator agent. Colloids Surf B Biointerfaces. 62(1):136–142.
  • Wen JC, Oliver SC, McCannel TA. 2009. Ocular complications following I-125 brachytherapy for choroidal melanoma. Eye. 23(6):1254–1268.
  • Yagawa O, Tanigawa K, Kobayashi Y, Yamamoto M. 2017. Cancer immunity and therapy using hyperthermia with immunotherapy, radiotherapy, chemotherapy, and surgery. J Cancer Metastasis Treat. 3(10):218–230.
  • Yang CM, Olsen KR, Schwade JG, Houdek PV, Markoe AM, Pisciotta V, Wu X. 1993. Dose rate effect of 125I irradiation on normal rabbit eyes and experimental choroidal melanoma. Exp Eye Res. 57(5):577–585.
  • Yarovoy AA, Magaramov DA, Bulgakova ES. 2012. The comparison of ruthenium brachytherapy and simultaneous transpupillary thermotherapy of choroidal melanoma with brachytherapy alone. Brachytherapy. 11(3):224–229.
  • Zhu L, Altman MB, Laszlo A, Straube W, Zoberi I, Hallahan DE, Chen H. 2019. Ultrasound hyperthermia technology for radiosensitization. Ultrasound Med Biol. 45(5):1025–1043.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.